Ignite Creation Date:
2024-07-17 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06463028
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-17
First Post:
2024-06-11
Brief Title:
Sapanisertib and Serabelisib PIKTOR With Paclitaxel Serabelisib With Paclitaxel and Paclitaxel Alone in Patients With AdvancedRecurrent Endometrial Cancer
Sponsor:
Faeth Therapeutics
Organization:
Faeth Therapeutics
Organization Data
Organization:
Faeth Therapeutics
Class:
INDUSTRY
Study ID:
FTH-PIK-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Faeth Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| GOG Foundation | NETWORK |